Prognostic impact and concordance of TERT promoter mutation and protein expression in matched primary and metastatic cutaneous melanoma

被引：0
|
作者：
Emilia Hugdahl
May Britt Kalvenes
Monica Mannelqvist
Rita G Ladstein
Lars A Akslen
机构：
[1] Centre for Cancer Biomarkers CCBIO,Department of Clinical Medicine
[2] University of Bergen,Department of Dermatology
[3] Haukeland University Hospital,Department of Pathology
[4] Haukeland University Hospital,undefined
来源：
British Journal of Cancer | 2018年 / 118卷
关键词：
nodular melanoma; metastases; promoter mutation; TERT protein expression; prognosis; inter-tumoural discordance; intra-tumoural discordance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：98 / 105
页数：7
相关论文
共 50 条
  • [21] TERT Promoter Mutation as an Independent Prognostic Marker for Poor Prognosis MAPK Inhibitors-Treated Melanoma
    Blateau, Pauline
    Coyaud, Etienne
    Laurent, Estelle
    Beganton, Benoit
    Ducros, Vincent
    Chauchard, Geraldine
    Vendrell, Julie A.
    Solassol, Jerome
    CANCERS, 2020, 12 (08) : 1 - 15
  • [22] Prognostic Impact of p62 Expression in Cutaneous Malignant Melanoma
    Ellis, Robert A.
    Horswell, Stuart
    Ness, Tom
    Lumsdon, Jonathan
    Tooze, Sharon A.
    Kirkham, Nigel
    Armstrong, Jane L.
    Lovat, Penny E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 (05) : 1476 - 1478
  • [23] Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma
    Kawasaki, K.
    Kawakami, T.
    Watabe, H.
    Itoh, F.
    Mizoguchi, M.
    Soma, Y.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (04) : 613 - 619
  • [24] Protein expression of prognostic genes in primary melanoma and benign nevi
    Gambichler, T.
    Elfering, J.
    Meyer, T.
    Bruckmueller, S.
    Stockfleth, E.
    Skrygan, M.
    Kaefferlein, H. U.
    Bruening, T.
    Lang, K.
    Wagener, D.
    Schroeder, S.
    Nick, M.
    Susok, L.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (10) : 2673 - 2680
  • [25] Protein expression of prognostic genes in primary melanoma and benign nevi
    T. Gambichler
    J. Elfering
    T. Meyer
    S. Bruckmüller
    E. Stockfleth
    M. Skrygan
    H. U. Käfferlein
    T. Brüning
    K. Lang
    D. Wagener
    S. Schröder
    M. Nick
    L. Susok
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2673 - 2680
  • [26] Association between TERT promoter mutations and BRAF/NRAS mutations in patients with primary and metastatic melanoma tumors
    Chang, Gregory A.
    Tadepalli, Jyothirmayee S.
    Fleming, Nathaniel H.
    Lui, Kevin
    Shao, Yongzhao
    Darvishian, Farbod
    Pavlick, Anna
    Berman, Russell
    Shapiro, Richard
    Osman, Iman
    Polsky, David
    CANCER RESEARCH, 2015, 75
  • [27] Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma
    Schlagenhauff, B
    Ellwanger, U
    Breuninger, H
    Stroebel, W
    Rassner, C
    Garbe, C
    MELANOMA RESEARCH, 2000, 10 (02) : 165 - 169
  • [28] Prognostic impact of discordance/concordance of triple-receptor expression between primary tumor and metastasis in patients with metastatic breast cancer
    Broglio, K.
    Moulder, S. L.
    Hsu, L.
    Kau, S.
    Pusztai, L.
    Symmans, W. F.
    Hortobagyi, G. N.
    Gonzalez-Angulo, A. M.
    Liedtke, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [29] Concordance of c-kit Mutational Status in Matched Primary and Metastatic Cutaneous Canine Mast Cell Tumors at Baseline
    Marconato, L.
    Zorzan, E.
    Giantin, M.
    Di Palma, S.
    Cancedda, S.
    Dacasto, M.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2014, 28 (02) : 547 - 553
  • [30] Comparing BRAF mutation status in matched primary and metastatic cutaneous melanomas: Implications on optimized targeted therapy
    Saroufim, Maya
    Habib, Robert H.
    Gerges, Rita
    Saab, Jad
    Loya, Asif
    Amr, Samir S.
    Sheikh, Salwa
    Satti, Mohammad
    Oberkanins, Christian
    Khalifeh, Ibrahim
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2014, 97 (03) : 315 - 320
12345